BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 35844506)

  • 21. Biomimetic Active Materials Guided Immunogenic Cell Death for Enhanced Cancer Immunotherapy.
    Huang G; Liu L; Pan H; Cai L
    Small Methods; 2023 May; 7(5):e2201412. PubMed ID: 36572642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emerging photodynamic nanotherapeutics for inducing immunogenic cell death and potentiating cancer immunotherapy.
    Zhang S; Wang J; Kong Z; Sun X; He Z; Sun B; Luo C; Sun J
    Biomaterials; 2022 Mar; 282():121433. PubMed ID: 35202933
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular determinants of immunogenic cell death elicited by radiation therapy.
    Galassi C; Klapp V; Yamazaki T; Galluzzi L
    Immunol Rev; 2024 Jan; 321(1):20-32. PubMed ID: 37679959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microbes mediated immunogenic cell death in cancer immunotherapy.
    Huang J; Duan F; Xie C; Xu J; Zhang Y; Wang Y; Tang YP; Leung EL
    Immunol Rev; 2024 Jan; 321(1):128-142. PubMed ID: 37553793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amplifying "eat me signal" by immunogenic cell death for potentiating cancer immunotherapy.
    Xi Y; Chen L; Tang J; Yu B; Shen W; Niu X
    Immunol Rev; 2024 Jan; 321(1):94-114. PubMed ID: 37550950
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting non-apoptotic cell death in cancer treatment by nanomaterials: Recent advances and future outlook.
    Sepand MR; Ranjbar S; Kempson IM; Akbariani M; Muganda WCA; Müller M; Ghahremani MH; Raoufi M
    Nanomedicine; 2020 Oct; 29():102243. PubMed ID: 32623018
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent progress in stimuli-responsive nanosystems for inducing immunogenic cell death.
    Banstola A; Poudel K; Kim JO; Jeong JH; Yook S
    J Control Release; 2021 Sep; 337():505-520. PubMed ID: 34314800
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Smart Nanosized Drug Delivery Systems Inducing Immunogenic Cell Death for Combination with Cancer Immunotherapy.
    Zhou L; Zhang P; Wang H; Wang D; Li Y
    Acc Chem Res; 2020 Sep; 53(9):1761-1772. PubMed ID: 32819102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination Cancer Immunotherapy of Nanoparticle-Based Immunogenic Cell Death Inducers and Immune Checkpoint Inhibitors.
    Qi J; Jin F; Xu X; Du Y
    Int J Nanomedicine; 2021; 16():1435-1456. PubMed ID: 33654395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stress-induced cellular responses in immunogenic cell death: Implications for cancer immunotherapy.
    Radogna F; Diederich M
    Biochem Pharmacol; 2018 Jul; 153():12-23. PubMed ID: 29438676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rediscovery of nanoparticle-based therapeutics: boosting immunogenic cell death for potential application in cancer immunotherapy.
    Yang S; Sun IC; Hwang HS; Shim MK; Yoon HY; Kim K
    J Mater Chem B; 2021 May; 9(19):3983-4001. PubMed ID: 33909000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunogenic Apoptosis as a Novel Tool for Anticancer Vaccine Development.
    Montico B; Nigro A; Casolaro V; Dal Col J
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29462947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cell death, therapeutics, and the immune response in cancer.
    Hänggi K; Ruffell B
    Trends Cancer; 2023 May; 9(5):381-396. PubMed ID: 36841748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emerging role of immunogenic cell death in cancer immunotherapy.
    Arimoto KI; Miyauchi S; Liu M; Zhang DE
    Front Immunol; 2024; 15():1390263. PubMed ID: 38799433
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel porphyrazine-based photodynamic anti-cancer therapy induces immunogenic cell death.
    Turubanova VD; Mishchenko TA; Balalaeva IV; Efimova I; Peskova NN; Klapshina LG; Lermontova SA; Bachert C; Krysko O; Vedunova MV; Krysko DV
    Sci Rep; 2021 Mar; 11(1):7205. PubMed ID: 33785775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of immunogenic cell death and its relevance for cancer therapy.
    Fucikova J; Kepp O; Kasikova L; Petroni G; Yamazaki T; Liu P; Zhao L; Spisek R; Kroemer G; Galluzzi L
    Cell Death Dis; 2020 Nov; 11(11):1013. PubMed ID: 33243969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oncolytic Immunotherapy: Dying the Right Way is a Key to Eliciting Potent Antitumor Immunity.
    Guo ZS; Liu Z; Bartlett DL
    Front Oncol; 2014; 4():74. PubMed ID: 24782985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Natural modulators of the hallmarks of immunogenic cell death.
    Radogna F; Dicato M; Diederich M
    Biochem Pharmacol; 2019 Apr; 162():55-70. PubMed ID: 30615863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanomedicine-mediated regulated cell death in cancer immunotherapy.
    Sun Y; Lian T; Huang Q; Chang Y; Li Y; Guo X; Kong W; Yang Y; Zhang K; Wang P; Wang X
    J Control Release; 2023 Dec; 364():174-194. PubMed ID: 37871752
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunogenic Cell Death Induction by Ionizing Radiation.
    Zhu M; Yang M; Zhang J; Yin Y; Fan X; Zhang Y; Qin S; Zhang H; Yu F
    Front Immunol; 2021; 12():705361. PubMed ID: 34489957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.